Royal Sense
BSE: ROYAL · Medical Equipment & Supplies
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Royal Sense's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Royal Sense Limited is an Indian distributor specialising in medical equipment, surgical instruments, and laboratory glassware. The company acts as a procurement partner for government institutions, public health departments, and private hospitals.
Business Model
The company operates as a supply chain intermediary, sourcing medical products from manufacturers to distribute to healthcare end-users. Revenue is primarily generated through government tenders and long-term supply contracts.
Management Commentary
Management focuses on maintaining a competitive position in the fragmented Indian healthcare market through strict quality compliance and reliable delivery schedules. The company has recently transitioned to the public markets via the BSE SME platform to support its expansion efforts.
Growth Outlook
Growth is driven by the expansion of the company's geographical footprint and the diversification of its product portfolio into advanced laboratory equipment and specialised surgical kits.
Key Risks
- Tender Dependency. The company's revenue is heavily reliant on winning government tenders, which are subject to intense competition and policy changes.
- Supply Chain Vulnerability. As a distributor, the company is exposed to potential disruptions in the supply chain from its third-party manufacturers.
- Market Fragmentation. The Indian medical equipment distribution sector is highly fragmented, leading to significant pricing pressure and thin margins.
- Regulatory Compliance. Failure to adhere to evolving medical quality standards and regulatory requirements could lead to contract cancellations or reputational damage.
Start your research today
Unlock AI insights, financials, peers and live data on Royal Sense and 5,000+ companies — free.
Peers · Medical Equipment & Supplies
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Royal SenseROYAL | ₹50 Cr | — | — | — | -15.0% | — | — | -66.2% |
Tarsons ProductsTARSONS | ₹1,785 Cr | 157.61 | 14.68 | 10.6% | 33.1% | 1.8% | 4.5% | +6.6% |
Laxmi DentalLAXMIDENTL | ₹1,072 Cr | 34.25 | 19.35 | — | 19.2% | 13.7% | 13.3% | -40.8% |
Hemant Surgical Industries LimitedHSIL | ₹894 Cr | — | — | — | 10.0% | — | — | +91.5% |
Vasa Denticity LimitedDENTALKART | ₹718 Cr | — | — | — | 4.2% | — | — | -24.1% |
Prevest DenproPREVEST | ₹461 Cr | — | — | — | 36.0% | — | — | -31.1% |
As of Mar 2026
Financials
Royal Sense
BSE: ROYAL · Medical Equipment & Supplies
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Royal Sense's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Royal Sense Limited is an Indian distributor specialising in medical equipment, surgical instruments, and laboratory glassware. The company acts as a procurement partner for government institutions, public health departments, and private hospitals.
Business Model
The company operates as a supply chain intermediary, sourcing medical products from manufacturers to distribute to healthcare end-users. Revenue is primarily generated through government tenders and long-term supply contracts.
Management Commentary
Management focuses on maintaining a competitive position in the fragmented Indian healthcare market through strict quality compliance and reliable delivery schedules. The company has recently transitioned to the public markets via the BSE SME platform to support its expansion efforts.
Growth Outlook
Growth is driven by the expansion of the company's geographical footprint and the diversification of its product portfolio into advanced laboratory equipment and specialised surgical kits.
Key Risks
- Tender Dependency. The company's revenue is heavily reliant on winning government tenders, which are subject to intense competition and policy changes.
- Supply Chain Vulnerability. As a distributor, the company is exposed to potential disruptions in the supply chain from its third-party manufacturers.
- Market Fragmentation. The Indian medical equipment distribution sector is highly fragmented, leading to significant pricing pressure and thin margins.
- Regulatory Compliance. Failure to adhere to evolving medical quality standards and regulatory requirements could lead to contract cancellations or reputational damage.
Start your research today
Unlock AI insights, financials, peers and live data on Royal Sense and 5,000+ companies — free.
Peers · Medical Equipment & Supplies
As of Mar 2026